A citation-based method for searching scientific literature

Anisur Rahman, David A Isenberg. N Engl J Med 2008
Times Cited: 1095







List of co-cited articles
501 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Michelle Petri, Ana-Maria Orbai, Graciela S Alarcón, Caroline Gordon, Joan T Merrill, Paul R Fortin, Ian N Bruce, David Isenberg, Daniel J Wallace, Ola Nived,[...]. Arthritis Rheum 2012
20

Systemic lupus erythematosus.
George C Tsokos. N Engl J Med 2011
17

The 1982 revised criteria for the classification of systemic lupus erythematosus.
E M Tan, A S Cohen, J F Fries, A T Masi, D J McShane, N F Rothfield, J G Schaller, N Talal, R J Winchester. Arthritis Rheum 1982
15

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.
Martin Aringer, Karen Costenbader, David Daikh, Ralph Brinks, Marta Mosca, Rosalind Ramsey-Goldman, Josef S Smolen, David Wofsy, Dimitrios T Boumpas, Diane L Kamen,[...]. Arthritis Rheumatol 2019
190
11

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J Wallace, Dana Tegzová, Jorge Sanchez-Guerrero, Andreas Schwarting, Joan T Merrill, W Winn Chatham,[...]. Arthritis Rheum 2011
720
8

Systemic lupus erythematosus disease activity index 2000.
Dafna D Gladman, Dominique Ibañez, Murray B Urowitz. J Rheumatol 2002
8

Systemic lupus erythematosus.
David P D'Cruz, Munther A Khamashta, Graham R V Hughes. Lancet 2007
445
8

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.
Martin Aringer, Karen Costenbader, David Daikh, Ralph Brinks, Marta Mosca, Rosalind Ramsey-Goldman, Josef S Smolen, David Wofsy, Dimitrios T Boumpas, Diane L Kamen,[...]. Ann Rheum Dis 2019
146
8

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
George K Bertsias, Maria Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg Bajema, Jo H M Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria,[...]. Ann Rheum Dis 2012
539
7


Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León,[...]. Lancet 2011
917
7

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.
Bevra H Hahn, Maureen A McMahon, Alan Wilkinson, W Dean Wallace, David I Daikh, John D Fitzgerald, George A Karpouzas, Joan T Merrill, Daniel J Wallace, Jinoos Yazdany,[...]. Arthritis Care Res (Hoboken) 2012
667
6

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Joan T Merrill, C Michael Neuwelt, Daniel J Wallace, Joseph C Shanahan, Kevin M Latinis, James C Oates, Tammy O Utset, Caroline Gordon, David A Isenberg, Hsin-Ju Hsieh,[...]. Arthritis Rheum 2010
650
6

Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
Richard Furie, Munther Khamashta, Joan T Merrill, Victoria P Werth, Kenneth Kalunian, Philip Brohawn, Gabor G Illei, Jorn Drappa, Liangwei Wang, Stephen Yoo. Arthritis Rheumatol 2017
336
6

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response.
Ronald F van Vollenhoven, Michelle A Petri, Ricard Cervera, David A Roth, Beulah N Ji, Christi S Kleoudis, Z John Zhong, William Freimuth. Ann Rheum Dis 2012
214
6

The BAFF/APRIL system in SLE pathogenesis.
Fabien B Vincent, Eric F Morand, Pascal Schneider, Fabienne Mackay. Nat Rev Rheumatol 2014
203
6

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, Martin Aringer, Ingeborg Bajema, John N Boletis, Ricard Cervera, Andrea Doria, Caroline Gordon, Marcello Govoni,[...]. Ann Rheum Dis 2019
308
6

The classification of glomerulonephritis in systemic lupus erythematosus revisited.
Jan J Weening, Vivette D D'Agati, Melvin M Schwartz, Surya V Seshan, Charles E Alpers, Gerald B Appel, James E Balow, Jan A Bruijn, Terence Cook, Franco Ferrario,[...]. J Am Soc Nephrol 2004
5

The frequency and outcome of lupus nephritis: results from an international inception cohort study.
John G Hanly, Aidan G O'Keeffe, Li Su, Murray B Urowitz, Juanita Romero-Diaz, Caroline Gordon, Sang-Cheol Bae, Sasha Bernatsky, Ann E Clarke, Daniel J Wallace,[...]. Rheumatology (Oxford) 2016
149
5

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.
Lynda Bennett, A Karolina Palucka, Edsel Arce, Victoria Cantrell, Josef Borvak, Jacques Banchereau, Virginia Pascual. J Exp Med 2003
5

New insights into the immunopathogenesis of systemic lupus erythematosus.
George C Tsokos, Mindy S Lo, Patricia Costa Reis, Kathleen E Sullivan. Nat Rev Rheumatol 2016
350
5

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
Brad H Rovin, Richard Furie, Kevin Latinis, R John Looney, Fernando C Fervenza, Jorge Sanchez-Guerrero, Romeo Maciuca, David Zhang, Jay P Garg, Paul Brunetta,[...]. Arthritis Rheum 2012
628
5

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.
William Stohl, Andreas Schwarting, Masato Okada, Morton Scheinberg, Andrea Doria, Anne E Hammer, Christi Kleoudis, James Groark, Damon Bass, Norma Lynn Fox,[...]. Arthritis Rheumatol 2017
111
5

Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus.
James Bentham, David L Morris, Deborah S Cunninghame Graham, Christopher L Pinder, Philip Tombleson, Timothy W Behrens, Javier Martín, Benjamin P Fairfax, Julian C Knight, Lingyan Chen,[...]. Nat Genet 2015
287
4

Mortality in systemic lupus erythematosus.
S Bernatsky, J-F Boivin, L Joseph, S Manzi, E Ginzler, D D Gladman, M Urowitz, P R Fortin, M Petri, S Barr,[...]. Arthritis Rheum 2006
605
4

Fcgamma receptors as regulators of immune responses.
Falk Nimmerjahn, Jeffrey V Ravetch. Nat Rev Immunol 2008
4

Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.
Gabor G Illei, Edward Tackey, Larissa Lapteva, Peter E Lipsky. Arthritis Rheum 2004
93
4

The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry.
George N Goulielmos, Maria I Zervou, Vassilis M Vazgiourakis, Yogita Ghodke-Puranik, Alexandros Garyfallos, Timothy B Niewold. Gene 2018
35
11

A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea.
Fengchun Zhang, Sang-Cheol Bae, Damon Bass, Myron Chu, Sally Egginton, David Gordon, David A Roth, Jie Zheng, Yoshiya Tanaka. Ann Rheum Dis 2018
55
7

Systemic lupus erythematosus.
Arvind Kaul, Caroline Gordon, Mary K Crow, Zahi Touma, Murray B Urowitz, Ronald van Vollenhoven, Guillermo Ruiz-Irastorza, Graham Hughes. Nat Rev Dis Primers 2016
234
4

Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.
José C Crispín, Mohamed Oukka, George Bayliss, Robert A Cohen, Christine A Van Beek, Isaac E Stillman, Vasileios C Kyttaris, Yuang-Taung Juang, George C Tsokos. J Immunol 2008
454
4

Systemic lupus erythematosus.
Larissa Lisnevskaia, Grainne Murphy, David Isenberg. Lancet 2014
345
4

Understanding the epidemiology and progression of systemic lupus erythematosus.
Guillermo J Pons-Estel, Graciela S Alarcón, Lacie Scofield, Leslie Reinlib, Glinda S Cooper. Semin Arthritis Rheum 2010
410
4


The classification of glomerulonephritis in systemic lupus erythematosus revisited.
Jan J Weening, Vivette D D'Agati, Melvin M Schwartz, Surya V Seshan, Charles E Alpers, Gerald B Appel, James E Balow, Jan A Bruijn, Terence Cook, Franco Ferrario,[...]. Kidney Int 2004
731
3

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.
C Bombardier, D D Gladman, M B Urowitz, D Caron, C H Chang. Arthritis Rheum 1992
3

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
3

Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Marie B Condon, Damien Ashby, Ruth J Pepper, H Terence Cook, Jeremy B Levy, Megan Griffith, Tom D Cairns, Liz Lightstone. Ann Rheum Dis 2013
212
3

B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab.
R John Looney, Jennifer H Anolik, Debbie Campbell, Raymond E Felgar, Faith Young, Lois J Arend, James A Sloand, Joseph Rosenblatt, Iñaki Sanz. Arthritis Rheum 2004
521
3

Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.
Christian Lood, Luz P Blanco, Monica M Purmalek, Carmelo Carmona-Rivera, Suk S De Ravin, Carolyne K Smith, Harry L Malech, Jeffrey A Ledbetter, Keith B Elkon, Mariana J Kaplan. Nat Med 2016
513
3

Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus.
Matthew D Linnik, Jay Z Hu, Kenneth R Heilbrunn, Vibeke Strand, Frank L Hurley, Tenshang Joh. Arthritis Rheum 2005
120
3

Anti-DNA antibodies--quintessential biomarkers of SLE.
David S Pisetsky. Nat Rev Rheumatol 2016
109
3

A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.
Gal Yaniv, Gilad Twig, Dana Ben-Ami Shor, Ariel Furer, Yaniv Sherer, Oshry Mozes, Orna Komisar, Einat Slonimsky, Eyal Klang, Eyal Lotan,[...]. Autoimmun Rev 2015
153
3

Accrual of organ damage over time in patients with systemic lupus erythematosus.
Dafna D Gladman, Murray B Urowitz, Proton Rahman, Dominique Ibañez, Lai-Shan Tam. J Rheumatol 2003
182
3

Current and novel therapeutics in the treatment of systemic lupus erythematosus.
Cagri Yildirim-Toruner, Betty Diamond. J Allergy Clin Immunol 2011
99
3

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
Munther Khamashta, Joan T Merrill, Victoria P Werth, Richard Furie, Kenneth Kalunian, Gabor G Illei, Jorn Drappa, Liangwei Wang, Warren Greth. Ann Rheum Dis 2016
246
3

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.
L Andreoli, G K Bertsias, N Agmon-Levin, S Brown, R Cervera, N Costedoat-Chalumeau, A Doria, R Fischer-Betz, F Forger, M F Moraes-Fontes,[...]. Ann Rheum Dis 2017
234
3


Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Sean R Christensen, Jonathan Shupe, Kevin Nickerson, Michael Kashgarian, Richard A Flavell, Mark J Shlomchik. Immunity 2006
673
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.